The fact that Rituxan appears to improve MS symptoms means it may share similarities to non-Hodgkins lymphoma and rheumatoid arthritis.
Encouraging results for MS drug
Rituxan is used to treat non-Hodgkin's lymphoma and rheumatoid arthritis. But in a study done at UC San Francisco, scientists found that MS patients who got Rituxan had a reduced number of brain lesions and a lower chance of relapse than those taking a placebo.
